Role of the MICA polymorphism in systemic lupus erythematosus
Kohsuke Yoshida
Kobe University Graduate School of Health Sciences, Kobe, Japan
Search for more papers by this authorKoichiro Komai
Kobe University Graduate School of Health Sciences, Kobe, Japan
Search for more papers by this authorKazuko Shiozawa
Center for Rheumatic Diseases, Konan-Kakogawa Hospital, Kakogawa, Japan
Search for more papers by this authorAya Mashida
Kobe University Graduate School of Health Sciences, Kobe, Japan
Search for more papers by this authorYuki Tanaka
Ehime University Graduate School of Medicine, Toon, Japan
Search for more papers by this authorMasato Nose
Ehime University Graduate School of Medicine, Toon, Japan
Search for more papers by this authorAkira Hashiramoto
Kobe University Graduate School of Health Sciences and Graduate School of Medicine, and Center for Rheumatic Diseases, Kobe University Hospital, Kobe, Japan
Search for more papers by this authorCorresponding Author
Shunichi Shiozawa
Kobe University Graduate School of Health Sciences and Graduate School of Medicine, Center for Rheumatic Diseases, Kobe University Hospital, and Global Center of Excellence, Kobe, Japan
Department of Medicine, Kobe University Graduate School of Medicine, 7-5 Kusunokicho, Chuoku 650-0017, JapanSearch for more papers by this authorKohsuke Yoshida
Kobe University Graduate School of Health Sciences, Kobe, Japan
Search for more papers by this authorKoichiro Komai
Kobe University Graduate School of Health Sciences, Kobe, Japan
Search for more papers by this authorKazuko Shiozawa
Center for Rheumatic Diseases, Konan-Kakogawa Hospital, Kakogawa, Japan
Search for more papers by this authorAya Mashida
Kobe University Graduate School of Health Sciences, Kobe, Japan
Search for more papers by this authorYuki Tanaka
Ehime University Graduate School of Medicine, Toon, Japan
Search for more papers by this authorMasato Nose
Ehime University Graduate School of Medicine, Toon, Japan
Search for more papers by this authorAkira Hashiramoto
Kobe University Graduate School of Health Sciences and Graduate School of Medicine, and Center for Rheumatic Diseases, Kobe University Hospital, Kobe, Japan
Search for more papers by this authorCorresponding Author
Shunichi Shiozawa
Kobe University Graduate School of Health Sciences and Graduate School of Medicine, Center for Rheumatic Diseases, Kobe University Hospital, and Global Center of Excellence, Kobe, Japan
Department of Medicine, Kobe University Graduate School of Medicine, 7-5 Kusunokicho, Chuoku 650-0017, JapanSearch for more papers by this authorAbstract
Objective
To study the genetic contribution of major histocompatibility complex class I polypeptide-related sequence A (MICA), important in natural killer (NK) cell function, in patients with systemic lupus erythematosus (SLE).
Methods
Japanese patients with SLE (n = 716), those with rheumatoid arthritis (RA) (n = 327), and healthy control subjects (n = 351) were genotyped for the Val129Met polymorphism (rs1051792) and transmembrane (TM) alanine-encoding GCT repeats, termed A4, A5, A5.1, A6, and A9, in the MICA gene. Recombinant human MICA-GST fusion proteins were tested on the NK cell line NK92MI for the expression of NK group 2, member D (NKG2-D), NK cell–mediated cytotoxicity, and interferon-γ (IFNγ) production.
Results
The MICA 129Met allele, TMA9 allele, and 129Met/Met genotype were positively associated with SLE (corrected P [Pcorr] = 0.01 and odds ratio [OR] 1.3, Pcorr = 0.003 and OR 1.6, and Pcorr = 0.02 and OR 1.8, respectively), while the MICA 129Val allele was negatively associated with SLE (Pcorr = 0.01, OR 0.8). The MICA 129Met;A9 haplotype was also associated with SLE (Pcorr = 0.0006, OR 1.8), and there was an additive genetic effect between the MICA 129Met;A9 haplotype and HLA–DRB1*15:01. When NK92MI cells were incubated in vitro with recombinant human disease-associated 129Met;A9 (the combination of polymorphisms at 129Met and TMA9), expression of NKG2-D on NK92MI cells and cytotoxicity of the NK cells were inhibited, but production of IFNγ from NK92MI cells was enhanced.
Conclusion
The MICA polymorphism is genetically associated with SLE, and MICA appears to contribute to the pathogenesis of SLE by modulating NK cell function.
REFERENCES
- 1 Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727–9.
- 2 Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3: 781–90.
- 3 Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 1996; 93: 12445–50.
- 4 Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc Natl Acad Sci U S A 1999; 96: 6879–84.
- 5 Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 2003; 100: 9452–7.
- 6 Yang D, Wang H, Ni B, He Y, Li J, Tang Y, et al. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-γ production in systemic lupus erythematosus. Mol Immunol 2009; 46: 1432–42.
- 7 Goto M, Tanimoto K, Chihara T, Horiuchi Y. Natural cell-mediated cytotoxicity in Sjögren's syndrome and rheumatoid arthritis. Arthritis Rheum 1981; 24: 1377–82.
- 8 Oshimi K, Sumiya M, Gonda N, Kano S, Takaku F. Natural killer cell activity in systemic lupus erythematosus. Lancet 1979; 2: 1023.
- 9 Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM, et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 2009; 60: 1753–63.
- 10 Aramaki T, Ida H, Izumi Y, Fujikawa K, Huang M, Arima K, et al. A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis. Mod Rheumatol 2009; 19: 245–52.
- 11 Takeda K, Dennert G. The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J Exp Med 1993; 177: 155–64.
- 12 Lo CK, Lam QL, Sun L, Wang S, Ko KH, Xu H, et al. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum 2008; 58: 2700–11.
- 13 Bahram S, Inoko H, Shiina T, Radosavljevic M. MIC and other NKG2D ligands: from none to too many. Curr Opin Immunol 2005; 17: 505–9.
- 14 Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y, et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci U S A 1997; 94: 1298–303.
- 15 Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001; 53: 279–87.
- 16 Sanchez E, Torres B, Vilches JR, Lopez-Nevot MA, Ortego-Centeno N, Jimenez-Alonso J, et al. No primary association of MICA polymorphism with systemic lupus erythematosus. Rheumatology (Oxford) 2006; 45: 1096–100.
- 17 Martinez A, Fernandez-Arquero M, Balsa A, Rubio A, Alves H, Pascual-Salcedo D, et al. Primary association of a MICA allele with protection against rheumatoid arthritis. Arthritis Rheum 2001; 44: 1261–5.
- 18 Lopez-Arbesu R, Ballina-Garcia FJ, Alperi-Lopez M, Lopez-Soto A, Rodriguez-Rodero S, Martinez-Borra J, et al. MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility. Rheumatology (Oxford) 2007; 46: 426–30.
- 19 Mok JW, Lee YJ, Kim JY, Lee EB, Song YW, Park MH, et al. Association of MICA polymorphism with rheumatoid arthritis patients in Koreans. Hum Immunol 2003; 64: 1190–4.
- 20 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7.
- 21 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
- 22 Amroun H, Djoudi H, Busson M, Allat R, El Sherbini SM, Sloma I, et al. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum Immunol 2005; 66: 1057–61.
- 23 Lee KO, Park TK, Park YS, Oh MJ, Kim YJ. DNA polymorphism analysis of the HLA-DRB1 gene using polymerase chain reaction-sequence specific primer (PCR-SSP) among Korean subjects. J Biochem Mol Biol 1996; 29: 45–51.
- 24 Aikawa Y, Morimoto K, Yamamoto T, Chaki H, Hashiramoto A, Narita H, et al. Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat Biotechnol 2008; 26: 817–23.
- 25 Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994; 43: 18–27.
- 26 Hashimoto H, Nishimura Y, Dong RP, Kimura A, Sasazuki T, Yamanaka K, et al. HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol 1994; 23: 191–6.
- 27 Ota M, Katsuyama Y, Kimura A, Tsuchiya K, Kondo M, Naruse T, et al. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics 2001; 71: 263–70.
- 28 Barcellos LF, May SL, Ramsay PP, Quach HL, Lane JA, Nititham J, et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 2009; 5: e1000696.
- 29 Oliveira LC, Porta G, Marin ML, Bittencourt PL, Kalil J, Goldberg AC. Autoimmune hepatitis, HLA and extended haplotypes. Autoimmun Rev 2011; 10: 189–93.
- 30 Shichi D, Kikkawa EF, Ota M, Katsuyama Y, Kimura A, Matsumori A, et al. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III–class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy. Tissue Antigens 2005; 66: 200–8.
- 31 Chen HI, Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci U S A 1995; 92: 7819–23.
- 32 Coates K, Harris M. The human immunodeficiency virus type 1 Nef protein functions as a protein kinase C substrate in vitro. J Gen Virol 1995; 76: 837–44.
- 33 Li GH, Fan YZ, Liu XW, Zhang BF, Yin DD, He F, et al. Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein. Mol Cell Biochem 2010; 340: 7–14.
- 34 Hoffman T. Natural killer function in systemic lupus erythematosus. Arthritis Rheum 1980; 23: 30–5.
- 35 Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, et al. Interferon-γ down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells. Int J Cancer 2009; 124: 1594–604.
- 36 Yadav D, Ngolab J, Lim RS, Krishnamurthy S, Bui JD. Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-γ-induced microRNA. J Immunol 2009; 182: 39–43.
- 37 Hughes TR, Tengku-Muhammad TS, Irvine SA, Ramji DP. A novel role of Sp1 and Sp3 in the interferon-γ-mediated suppression of macrophage lipoprotein lipase gene transcription. J Biol Chem 2002; 277: 11097–106.
- 38 Armstrong SA, Barry DA, Leggett RW, Mueller CR. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J Biol Chem 1997; 272: 13489–95.
- 39 Harris SM, Harvey EJ, Hughes TR, Ramji DP. The interferon-γ-mediated inhibition of lipoprotein lipase gene transcription in macrophages involves casein kinase 2- and phosphoinositide-3-kinase-mediated regulation of transcription factors Sp1 and Sp3. Cell Signal 2008; 20: 2296–301.
- 40 Venkataraman GM, Suciu D, Groh V, Boss JM, Spies T. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J Immunol 2007; 178: 961–9.
- 41 Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13: 58–67.
- 42 Haas C, Ryffel B, Le Hir M. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J Immunol 1997; 158: 5484–91.
- 43 Balomenos D, Rumold R, Theofilopoulos AN. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest 1998; 101: 364–71.
- 44 Lawson BR, Prud'homme GJ, Chang Y, Gardner HA, Kuan J, Kono DH, et al. Treatment of murine lupus with cDNA encoding IFN-γR/Fc. J Clin Invest 2000; 106: 207–15.
